
pmid: 24235190
pmc: PMC3828093
My patient received 62 units of botulinum toxin type A (BTX-A) for facial lines. Two weeks later, she found out that she was pregnant. Will this cause any harm to her fetus?Botulinum toxin is not expected to be present in systemic circulation following proper intramuscular or intradermal injection. Moreover, BTX-A, which has a high molecular weight, does not appear to cross the placenta. From the 38 pregnancies reported in the literature, including women who had botulism poisoning during pregnancy, exposure to BTX-A does not appear to increase the risk of adverse outcome in the fetus.
Injections, Intradermal, Neuromuscular Agents, Pregnancy, Prenatal Exposure Delayed Effects, Humans, Female, Botulinum Toxins, Type A, Injections, Intramuscular, Maternal-Fetal Exchange, Skin Aging
Injections, Intradermal, Neuromuscular Agents, Pregnancy, Prenatal Exposure Delayed Effects, Humans, Female, Botulinum Toxins, Type A, Injections, Intramuscular, Maternal-Fetal Exchange, Skin Aging
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 18 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
